ATM and neoplasm: When a germline ATM mutation is discovered, several centers use paired tumor-normal sequencing to document biallelic inactivation because the clinical impact frequently depends on whether tumors acquire a second hit (such as a loss of heterozygosity or a somatic ATM change) [230].